Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

Histopathology

Volumn 38, Issue 2, 2001, Pages 120-134

  D'Andrea, M R ^a,c   Nagele, R G ^a,b   Wang, H Y ^a   Peterson, P A ^a   Lee, D H S ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c R W Johnson Pharmaceutical Res I   (United States)

Author keywords

amyloid; Alzheimer's disease; Amyloid plaque; Cell lysis; Entorhinal cortex; Hippocampus; Pyramidal cell

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CYTOLYSIS; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ENTORHINAL CORTEX; EXOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PEPTIDE FRAGMENTS; PYRAMIDAL CELLS; SENILE PLAQUES;

EID: 0035120525     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01082.x     Document Type: Article

References (61)

1. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
2. The molecular pathology of Alzheimer's disease
3. Neuropathological staging of Alzheimer-related changes
4. Pathogenesis of Alzheimer-related neuritic plaques: aT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala
5. Making the diagnosis of Alzheimer's Disease
6. New neuropathological criteria for Alzheimer's disease
7. Extracellular neurofibrillary tangles associated with degenerating neurites and neuropil threads in Alzheimer-type dementia
8. Paired helical filament tau in Alzheimer's disease. The kinase connection
9. Amyloid plaque core protein in Alzheimer disease and Down syndrome
10. Normal and abnormal biology of the beta-amyloid precursor protein
11. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
12. Amyloid beta-protein and the genetics of Alzheimer's disease
13. The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?
14. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease
15. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
16. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
17. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases
18. Neuropathology in the Down's syndrome brain
19. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis
20. Evidence that A beta 42 is the real culprit in Alzheimer's disease
21. Intracellular APP processing and A beta production in Alzheimer disease
22. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
23. Two transmembrane aspartates in presenilin 1 required for presenilin endoproteolysis and gamma-secretase activity
24. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta protein in both transfected cells and transgenic mice
25. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
26. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
27. Alzheimer's disease: A re-examination of the amyloid hypothesis
28. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease
29. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation
30. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture
31. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42
32. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
33. Alzheimer's A beta (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
34. Intraneuronal Abeta42 accumulation in human brain
35. 1-42 binds to alpha 7 nicotinic acetylcholine receptor with high affinity: Implications for Alzheimer's disease pathology
36. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues
37. Enzymatically active lyosomal proteases are associated with amyloid deposits in Alzheimer brain
38. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: Evidence for neuronal origin
39. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease
40. The presence, origin and significance of Abeta peptide in the cell bodies of neurons
41. Topographic heterogeneity of amyloid beta-protein epitopes in brains with various forms of lipofuscinoses suggesting defective processing of amyloid precursor protein
42. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein
43. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein
44. Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons
45. Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation
46. Intracellular production of beta A, 4 amyloid of Alzheimer's disease A. Modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein
47. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi
48. Expression of beta-amyloid precursor protein-CD3y chimeras to demonstrate the selective generation of amyloid beta1-40 and amyloid beta1-42 peptides within secretory and endocytic compartments
49. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
50. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
51. Comparison of the regional expression of nicotinic acetylcholine receptor alpha 7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain
52. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques
53. RNA sequestration to pathological lesions of neurodegenerative diseases
54. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
55. Increased neuronal endocytosis and protease delivery to early endosomes in sporatic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis
56. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis
57. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor protein
58. Mechanisms of cell death in Alzheimer's disease
59. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
60. Widespread peroxynitrite-mediated damage in Alzheimer's disease
61. Immunohistochemical evidence for apoptosis in Alzheimer's disease